Stock screenerAll disclosures →
EDGAR →
MRNA
Conviction 82HealthcareScan · Fri, Jun 26, 2026MRNA$67.27+12.59%
ResistanceSupportVol 14Insider sellCongress buyCongress sellVol MA14 9.79M
Mar 27Apr 15May 4May 20Jun 9Jun 26
WSB mentions · 24h changelatest -25.00%· 3 mentions
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price67.27
Change+12.59%
Gap-0.55%
Rel volume2.92×
Avg volume8.75M
Avg $ vol496.73M
SMA 2053.45
SMA 5051.16
SMA 20040.14
Price vs 50+31.50%
Price vs 200+67.57%
MA stackbullish
50/200 cross—
Supertrendup · 52.12
RSI (14)71
MACD hist1.40
MACD cross—
Stoch %K / %D92 / 74
ADX (14)26
+DI / −DI37 / 13
RSI divergence—
MACD divergence—
ATR %+6.69%
ADR %7.92%
52w high67.27
52w low22.36
From 52w high+0.00%
Above 52w low+200.85%
New 52w highYes
SqueezeOff
Bollinger width50.76%
%B1.01
Donchian pos92.12%
Donchian high69.27
Donchian low43.90
AVWAP (52w high)65.30
vs AVWAP high+3.02%
AVWAP (52w low)44.99
vs AVWAP low+49.53%
OBV trendUp
Chaikin MF (20)0.15
Today vs 20d2.92×
Avg vol (14d)9.79M
Avg vol (20d)8.75M
Avg $ vol (20d)496.73M
Market cap—
RS 3m (vs SPY)-0.20%
RS 6m (vs SPY)+63.98%
RS line new highNo
Trend template7/8
Technical rank96.0
1 week+5.18%
1 month+41.29%
3 months+25.57%
6 months+108.33%
1 year+150.45%
YTD+117.98%
P/E-8.40
P/B3.20
P/S12.19
P/FCF-11.48
EPS-7.26
Div yield—
ROE-38.09%
ROA-24.56%
Debt/Eq0.08
Current2.41
EV/EBITDA-7.82
Gross margin—
Net margin-145.16%
Rev growth-39.93%
EPS growth20.75%
Price target44.84
Target upside-24.94%
Analyst ratingHold
Institutional90.77%
Ent. value22.39B
Revenue389M
Net income-1.34B
Gross profit—
Free cash flow-2.06B
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out396.79M
Employees4.7K
ListedFri, Dec 7, 2018
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction82 / 100
Pattern quality—
Tech rank96.0 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance63.61
Support44.65
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MRNA · 3 recent
Insider activity
SEC Form 4 transactions in MRNA · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Mock James M Chief Financial Officer · Restricted Stock Units · 2026-06-05 | Exercise | 11.8K | $0 | 2026-06-05 | 2026-06-08 |
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-06-05 | Tax | 5.71K | $294K | 2026-06-05 | 2026-06-08 |
Mock James M Chief Financial Officer · Common Stock · 2026-06-05 | Tax | 5.71K | $294K | 2026-06-05 | 2026-06-08 |
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-06-05 | Exercise | 11.8K | — | 2026-06-05 | 2026-06-08 |
Klinger Shannon Thyme Chief Legal Officer · Restricted Stock Units · 2026-06-05 | Exercise | 11.8K | $0 | 2026-06-05 | 2026-06-08 |
Mock James M Chief Financial Officer · Common Stock · 2026-06-05 | Exercise | 11.8K | — | 2026-06-05 | 2026-06-08 |
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-06-04 | Exercise | 3.47K | $107K | 2026-06-04 | 2026-06-08 |
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-06-04 | Sell | 3.47K | $174K | 2026-06-04 | 2026-06-08 |
Klinger Shannon Thyme Chief Legal Officer · Stock Option (Right to Buy) · 2026-06-04 | Exercise | 3.47K | $0 | 2026-06-04 | 2026-06-08 |
Klinger Shannon Thyme Chief Legal Officer · Common Stock · 2026-06-01 | Exercise | 2.17K | — | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in MRNA · 3 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.